Abstract
Introduction
 The underlying systematic review was conducted according to the PRISMA guidelines. [6]  Details on the underlying methodology of this systematic review are described in detail elsewhere [7] , hence below only a short description of the methodology is provided.  Eligible studies were decision models for full economic assessment in the context of the prevention and / or therapy of obesity.  Data Extraction: For the data extraction a predefined template was developed and used in order to summarize information on the obesity associated events simulation approaches.  This included the following information: CVD / T2D / stroke incidence simulation approach, CVD / T2D / stroke simulation of the intervention effect, event-specific mortality simulation, rating on whether reprogramming is possible on the basis of the data / information provided, and information on the validation of the event simulation.  Obesity is a multifactorial, chronic disorder that has, according to the World Health Organization (WHO), reached epidemic proportions globally and is a major contributor to the global burden of chronic disease and disability [1] .  Obesity is defined as abnormal or excessive fat accumulation that may impact health. The body mass index (BMI) is a simple index of weight-for-height that is commonly used to classify obesity in adults. It is defined as a person's weight in kilograms divided by the square of his height in meters (kg/m2). According to the WHO definition, a BMI ≥ 25 and < 30 is overweight; a BMI ≥30 is obesity [1] .  In 2014, worldwide, more than 1.9 billion adults (≈39%), 18 years and older, were overweight. Of these, over 600 million adults (≈13%) were obese [2] .  Overweight and obesity are leading risks for global deaths. In 2010, worldwide, it has been estimated that around 3.4 million adults died (≈ 6% of total deaths per year) as a result of being overweight or obese. [3] In addition, 44% of the diabetes cases, 23% of the ischemic heart disease cases and between 7% and 41% of certain cancer cases are attributable to overweight and obesity [4] .  Given this clinical and its associated economic burden, it is of major interest for healthcare decision makers to identify costeffective programs or interventions for obesity prevention and therapy.  Decision analytic modelling is particularly relevant in the case of prevention and therapy of obesity due to the chronic nature of the obesity associated morbidities (e.g. diabetes, coronary heart disease, stroke, osteoarthritis and specific cancer types) and the related mortality.  For assessing the long-term health economic impact of such programs, several decision analytic models have been applied.  The objective of our research was to determine, compare and critically appraise the methodological variations in the event simulation approaches of published health economic decision models.  The focus was set on cardiovascular diseases (CVD); type 2 diabetes (T2D) and stroke as cohort studies have demonstrated that these diseases are three of the most important consequences of obesity. 
Discussion
 In our systematic review we have identified 87 papers on decision models that were fulfilling all three inclusion criteria (decision model, full HEA, focus on obesity); and 68 (78% of the total) of these models simulated at least one of the key obesity associated events (CHD, T2D, stroke).  Although we have identified a huge variation in the base risk and the intervention effect simulation approaches we were able to identify and group comparable event simulation approaches, in order to provide insights on the frequency of their application in the context of obesity.  To guide future modelling in the field of obesity a valuable next step would be to present more details on the identified key approaches, to reprogram them, and to compare the outcomes of these key event simulation approaches when simulating comparable patient populations and comparable intervention effects.  Furthermore a comparison of these outcomes to epidemiological long-term studies (external validation) would be very interesting in order to inform modelers and decision makers on the predictiveness of the identified event simulation approaches.  This future research could inform the development of recommendations and/or minimal requirements for model-based HEAs in the context of obesity prevention and therapy. 
Results
 In total 4,293 studies were identified via the database searches, 4,304 abstracts were reviewed (database search plus n=11 hand search). Out of these 142 articles selected for full-text review, 87 papers met our inclusion criteria.  Out of the 87 decision models identified 72 (83% of the total) simulated obesity associated events; and 68 (78% of the total) of these models simulated at least one of the key obesity associated events (CHD, T2D and/or stroke).  Looking at the single events we have identified 60 decision models (69% of the total) that simulated CVD; 53 decision models (61% of the total) that simulated T2D and 48 decision models (55% of the total) that simulated stroke; only 39 (45% of the total) decision models simulated all three events.  Details on the events simulation approaches for CVD, T2D and stroke are presented in figure 1, figure 2 and figure 3 , respectively.  Looking at CVD events the Framingham algorithms [8] were the most frequently applied method for estimating the CVD incidence, in this cases the intervention effect was estimated by simulating the intervention's impact on the equation's risk factors.  Looking at the second most and the third most applied approaches, BMI related or BMI group related relative risks (RR) were applied in order to estimate the intervention effect on the frequency of CVD events; here various approaches were used in order to estimate the CVD base risk and the most frequently applied were estimating the potential impact fraction or CVD incidence estimates on the basis of population characteristics (such as age & gender).
 As shown in figure 3 the stroke event simulation approaches were largely comparable to the approaches identified for the CVD risk calculation.  This means there is a mixture between approaches that apply on one hand sophisticated algorithms (such as Framingham or UKPDS) where the intervention effect is estimated by the effect on risk factors, and on the other hand BMI, BMI group, or obesity status related RR estimates to simulate the intervention effect in combination with various approaches for the stroke based risk estimation (e.g. potential impact fraction or stroke incidence estimates on the basis of population characteristics).
 Considering those decision models that have simulated specific obesity related events we have found that 93% (56 of 60) simulated CVD-specific mortality; 44% (23 of 53) simulate a T2D-specific mortality rate and 98% (47 of 48) simulate a stroke-specific mortality rate.  Reprogramming of the approach on the basis of the data / information provided in the related publications was estimated to be possible for 45% (27 of 60) of the CVD event simulation approaches, for 43% (23 of 53) of the T2D event simulation approaches and for 38% (18 of 47) of the stroke simulation approaches.  Any validation procedures (internal, external or cross-validation) were described for 22% (15 of 68) of the decision models that simulated CVD, T2D and/or stroke.  Looking at the T2D event simulation approaches provided in figure 2 , BMI functions were the most frequently applied method to estimate the T2D base risk. The intervention effect was in this case simulated by recalculating the BMI function using the effect of the intervention on the BMI as central influence parameter.  This BMI or obesity status (defined by BMI) related intervention effect calculation was observed in most of the T2D modelling approaches.  Furthermore we have identified that only 15 (28%) of 53 decision models that simulating T2D were enabling a remission from obesity associated T2D. OBJECTIVES: Decision analytic modelling is particularly relevant in the case of prevention and therapy of obesity due to the chronic nature of the obesity associated morbidities (e.g. diabetes, coronary heart disease, stroke, osteoarthritis and specific cancer types) and the related mortality. For assessing the long-term health economic impact of such programs, several decision analytic models have been applied. The objective of our research was to determine, compare and critically appraise the methodological variations in the event simulation approaches of published health economic decision models.
METHODS:
A systematic review was performed in Pubmed and NHSEED to identify decision models for full health economic assessments (HEA) in obesity, applying the PRISMA guidelines. For each included study, we extracted information about the event simulation approach including type of obesity associated events, event specific base risk, impact of obesity program/intervention on the event base risk, time horizon, model type and others.
